Fennec Pharmaceuticals (ADH) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q2 2025
Q3 2025
-0.22
-0.16
-0.09
-0.03

Details

Expected EPS
-0.0348542285
Actual EPS
-0.1114243845
Surprise EPS
-0.08
Surprise Percent
+219.69%

Description

Fennec Pharmaceuticals (ADH) has reported earnings of -0.1114243845 per share for Q3 2025.

0 Comments

Share your thoughts